Cancer of the gastroesophageal junction: a diagnosis, classification, and management review
Management of gastroesophageal junction (GEJ) adenocarcinoma is a controversial topic. The rising incidence of this cancer requires a clear consensus to ensure proper management. Application of oncological principles for tumors of the esophagus or stomach is not possible because of comparative diffe...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
23 August 2018
|
| In: |
Annals of the New York Academy of Sciences
Year: 2018, Volume: 1434, Pages: 132-138 |
| ISSN: | 1749-6632 |
| DOI: | 10.1111/nyas.13954 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1111/nyas.13954 Verlag, Volltext: https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/nyas.13954 
|
| Author Notes: | Mickael Chevallay, Elfriede Bollschweiler, Servarayan M. Chandramohan, Thomas Schmidt, Oliver Koch, Giovanni Demanzoni, Stefan Mönig, William Allum |
| Summary: | Management of gastroesophageal junction (GEJ) adenocarcinoma is a controversial topic. The rising incidence of this cancer requires a clear consensus to ensure proper management. Application of oncological principles for tumors of the esophagus or stomach is not possible because of comparative differences in the biology of GEJ adenocarcinoma, leading to different therapeutic options. Staging work-up with endoscopy, endosonography, and PET is essential to inform the choice of neoadjuvant treatment and surgical approach to GEJ adenocarcinoma. Surgery remains the only curative treatment and should be undertaken in specialized centers. |
|---|---|
| Item Description: | Gesehen am 25.04.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1749-6632 |
| DOI: | 10.1111/nyas.13954 |